ZNTL
Zentalis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.99
−2.92%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-121.8%
Return on equity
-81.2%
Return on assets
-105.5%
Return on invested capital
0.00x
Asset turnover
-$161.1M
Cash from operations
$1.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026